Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
Skinner, S Rachel, PhD, Szarewski, Anne, PhD, Romanowski, Barbara, Prof, Garland, Suzanne M, Prof, Lazcano-Ponce, Eduardo, Prof, Salmerón, Jorge, Prof, Del Rosario-Raymundo, M Rowena, MD, Verheijen, René H M, Prof, Quek, Swee Chong, MBBCh, da Silva, Daniel P, MD, Kitchener, Henry, Prof, Fong, Kah Leng, MRCOG, Bouchard, Céline, FRCSC, Money, Deborah M, Prof, Ilancheran, Arunachalam, MD, Cruickshank, Margaret E, Prof, Levin, Myron J, Prof, Chatterjee, Archana, Prof, Stapleton, Jack T, Prof, Martens, Mark, MD, Quint, Wim, PhD, David, Marie-Pierre, MSc, Meric, Dorothée, MSc, Hardt, Karin, PhD, Descamps, Dominique, MD, Geeraerts, Brecht, PhD, Struyf, Frank, MD, Dubin, Gary, MD
Published in The Lancet (British edition) (20.12.2014)
Published in The Lancet (British edition) (20.12.2014)
Get full text
Journal Article